靶向磁共振成像-超声融合前列腺活检中核心数量与位置的作用
本研究探讨MRI-超声融合前列腺活检中充分检测临床显著前列腺癌所需的核心数量和位置。744例患者581个病灶中,两核心采样检测到77%的G≥3+4肿瘤和72%的G>3+4肿瘤,但遗漏16%首诊、27%既往阴性及32%主动监测患者的临床显著癌。两核心采样遗漏近四分之一额外采样可检出的临床显著前列腺癌。
要点
- 两核心采样检测到77%(279/361)的G≥3+4肿瘤和72%(137/189)的G>3+4肿瘤。
- 两核心采样遗漏16%首诊、27%既往阴性、32%主动监测患者的临床显著癌。
- G≥3+4癌症检出率不因核心位置而异。
核心结论
- 两核心采样遗漏近四分之一额外采样可检出的临床显著前列腺癌。
- 五核心采样较两核心采样遗漏的癌症显著减少。
研究设计与样本
- 在本机构接受MRI-超声融合前列腺活检的患者,因已知病史或临床怀疑前列腺癌。
- 多参数MRI采用Likert和PI-RADS v2评分系统审阅。
- 每个感兴趣区取多个靶向核心后行12针系统活检。
- 另一独立队列采用预定的五核心模板靶向病灶。
- 识别744例患者581个前列腺癌病灶。
主要发现
- 77%(279/361)的G≥3+4肿瘤和72%(137/189)的G>3+4肿瘤经两核心采样检出。
- 两核心采样较所有靶向核心遗漏16%首诊、27%既往阴性、32%主动监测患者的临床显著癌。
- G≥3+4癌症检出率不因核心位置而异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The optimal method of magnetic resonance imaging (MRI)-ultrasound (US) fusion biopsy to adequately sample regions of interest (ROIs) remains unknown. We sought to determine the number and location of cores needed to adequately detect clinically significant prostate cancer (PCa). We identified patients undergoing MRI-US fusion prostate biopsy at our institution for known history or clinical suspicion of PCa. Multiparametric MRI studies were reviewed using Likert and Prostate Imaging Reporting and Data System (PI-RADS) v2 schema. Multiple targeted cores were taken from each ROI followed by 12-core systematic biopsy. In a distinct cohort of patients, lesions were targeted using a predetermined five-core template. We estimated cancers detected through sampling of five or fewer cores, assessed by core number and core location. We identified 744 patients with 581 lesions with PCa. Seventy-seven percent (279/361) of Gleason (G) ≥3+4 tumors and 72% (137/189) of G >3+4 tumors were detected on two-core sampling. Relative to all targeted cores, a two-core approach missed 16% of clinically significant cancers at first biopsy, 27% in prior negative, and 32% in active surveillance patients. Detection of G ≥3+4 cancers did not differ by core location. Sampling of two cores of ROIs misses nearly one-quarter of clinically significant PCa detected on additional sampling. PATIENT SUMMARY: We aimed to understand how the number of cores obtained from a suspicious area during prostate magnetic resonance imaging-ultrasound fusion biopsy affects cancer detection. We found that sampling of five cores missed substantially fewer cancers compared to two cores.
引用
- Lu AJ, Syed JS, Ghabili K, et al. Role of Core Number and Location in Targeted Magnetic Resonance Imaging-Ultrasound Fusion Prostate Biopsy. Eur Urol. 2019. PMID: 31047733. doi:10.1016/j.eururo.2019.04.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。